InvestorsHub Logo
Followers 438
Posts 41282
Boards Moderated 0
Alias Born 10/07/2010

Re: MG123 post# 4522

Tuesday, 10/10/2017 10:27:13 AM

Tuesday, October 10, 2017 10:27:13 AM

Post# of 8360
The Research: All source information contained in this email is from the public sources mentioned below.

OTC Markets
FINRA Short Reporting
Yahoo Finance


Thank you

MonstaMoMo

@MonstaMoMoMo



Disclaimer: MonstaMoMo publishes reports providing information on selected companies. MonstaMoMo is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. MonstaMoMo accepts no liability for any loss arising from an investor's reliance on or use of this report. An investment in ETST is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. MonstaMoMo has received up to $37,500 from a non-affiliated third party for the publication and circulation of this report. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2016 by MonstaMoMo. All rights reserved. Our Full Disclaimer: http://otc.report/disclaimer



This email was sent by: MonstaMoMo
You were sent this email because you have subscribed at one of our websites.


BreakingNews: >> ETST << Earth Science Tech, Inc. Partners with Centre SIDA Amite Clinic to Commence Final Pre-Launch MSN-2 Clinical Human Trial Study

The mini-clinical trial is the last trial needed to allow for the launch of the MSN-2 device!

Doral, FL, Oct. 10, 2017 (GLOBE NEWSWIRE) -- Earth Science Tech, Inc. (OTC PINK: ETST


Blah blah blah
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ETST News